Westlake Q3 sales beat estimates on higher sales prices, profitability plan benefits

By Reuters News


Overview

  • Chemicals and building products maker's Q3 sales rose, beating analyst expectations

  • Adjusted net income improved yr/yr, driven by higher sales prices and profitability plan benefits

  • Company recorded charges for previously announced facility shutdowns, including a PVC plant in Germany


Outlook

  • Company expects higher borrowing costs to weigh on HIP near-term sales volumes

  • Westlake sees medium- to long-term HIP growth supported by infrastructure spending and investments

  • Company says PEM selling prices have stabilized with upward momentum entering Q4 2026


Result Drivers

  • PEM SEGMENT PRICING - Higher average sales prices in Performance and Essential Materials segment contributed to yr/yr earnings improvement

  • EUROPEAN ENERGY AND DEMAND - PEM segment earnings were negatively affected by higher energy costs, weak demand, and increased import pressure in Europe

  • HIP VOLUME AND COSTS - Housing and Infrastructure Products segment was impacted by lower sales volumes, especially for pipe & fittings, and higher distribution costs


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$2.98 bln

$2.95 bln (14 Analysts)

Q3 EPS

$0.05

Q3 Net Income

$6 mln

Q3 Pretax Profit

$8 mln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy", 11 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the commodity chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Westlake Corp is $76.00, about 11% above its November 3 closing price of $68.47

  • The stock recently traded at 30 times the next 12-month earnings vs. a P/E of 23 three months ago


Reuters Recommended Reads

  • Nov 2 - Celanese Q3 sales rise 6%

  • Nov 2 - Chemours Q3 adjusted profit misses estimates despite titanium pricing gains

  • Nov 3 - DuPont Q3 sales beat estimates, lifts 2026 profit outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.